Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rab escort protein 1 (REP1), encoded by the CHM gene, is a critical component of the Rab geranylgeranyltransferase (GGTase) complex essential for the post-translational modification of Rab GTPases (UniProt P24386). Its primary biological function is to bind newly synthesized Rab proteins and present them to the catalytic subunit of Rab GGTase for prenylation, a lipid modification necessary for membrane anchoring and the regulation of intracellular trafficking (NCBI Gene ID: 1121). In humans, a deficiency in REP1 leads to Choroideremia, a rare X-linked recessive retinal degeneration characterized by the progressive loss of the choroid, retinal pigment epithelium, and photoreceptors (MacLaren et al., 2014). While a closely related isoform, REP2, can compensate for REP1 in most tissues, it is insufficient in the retina, leading to the tissue-specific disease phenotype. Therapeutic strategies for this target focus on gene replacement therapy, utilizing adeno-associated virus (AAV) vectors to deliver a functional copy of the CHM gene to the subretinal space (Dimopoulos et al., 2018). These treatments aim to restore prenylation activity and halt the progression of vision loss in affected patients.
Gene replacement therapy via adeno-associated virus (AAV) vector delivery of a functional CHM gene to restore Rab escort protein 1 activity and Rab prenylation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rab escort protein 1 (CHM) (REP1).